Switzerland vs Venezuela: The number of people with susceptibility test result for rifampicin
Switzerland
220
in 2021
Venezuela
198
in 2021
Switzerland rank
92nd
Venezuela rank
94th
The number of people with susceptibility test result for rifampicin over time
- Switzerland
- Venezuela
How they compare
Switzerland currently reports 220 against 198 in Venezuela, a difference of 22.
That makes Switzerland's figure about 1.1 times Venezuela's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Venezuela ahead.
Switzerland ranks 92nd and Venezuela ranks 94th of 155 countries.
Across the 2 decades both report, Switzerland averaged higher in 1 and Venezuela in 1.
Head to head by decade
| Decade | Switzerland | Venezuela | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 240.33 | 383 | 142.67 | Venezuela |
| 2020s | 195.5 | 152.5 | 43 | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Switzerland or Venezuela?
- Switzerland, at 220 against 198 in Venezuela as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Switzerland and Venezuela?
- 22, with Switzerland ahead.
- How many years of comparable data are there for Switzerland and Venezuela?
- 5 years are reported by both, from 2017 to 2021.
- How do Switzerland and Venezuela rank globally for the number of people with susceptibility test result for rifampicin?
- Switzerland ranks 92nd and Venezuela ranks 94th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.